Aprea Therapeutics, Inc. Contracts & Agreements
39 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (5)
- Human Resources (17)
- Mergers & Acquisitions (1)
- Uncategorized (3)
- DESCRIPTION OF REGISTRANTS SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 26, 2024)
- Placement Agency Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on March 12, 2024)
- Form of Registration Rights Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics and the purchasers (Filed With SEC on March 12, 2024)
- Form of Securities Purchase Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics, Inc. and the purchasers named therein (Filed With SEC on March 12, 2024)
- Form of Tranche B Warrant (Filed With SEC on March 12, 2024)
- Form of Tranche A Warrant (Filed With SEC on March 12, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 12, 2024)
- Confidential Severance Agreement and General Release between Aprea Therapeutics, Inc. and Scott M. Coiante (Filed With SEC on March 30, 2023)
- DESCRIPTION OF REGISTRANTS SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 30, 2023)
- Separation and General Release Agreement between Aprea Therapeutics, Inc. and Christian S. Schade (Filed With SEC on March 30, 2023)
- Employment Agreement between Aprea Therapeutics, Inc. and Eyal Attar (Filed With SEC on March 30, 2023)
- Separation and General Release Agreement between Aprea Therapeutics, Inc. and Eyal Attar (Filed With SEC on March 30, 2023)
- Separation and General Release Agreement between Aprea Therapeutics, Inc. and Lars Abrahmsen (Filed With SEC on March 30, 2023)
- Retention Letter Agreement between Aprea Therapeutics, Inc. and Gregory A. Korbel, Ph.D (Filed With SEC on March 30, 2023)
- Separation Agreement and General Release between Aprea Therapeutics, Inc. and Gregory A. Korbel, Ph.D (Filed With SEC on March 30, 2023)
- Retention Letter Agreement between Aprea Therapeutics, Inc. and Scott M. Coiante (Filed With SEC on March 30, 2023)
- Employment Agreement between Aprea Therapeutics, Inc. and Oren Gilad (Filed With SEC on March 30, 2023)
- Employment Agreement between Aprea Therapeutics, Inc. and John P. Hamill (Filed With SEC on March 30, 2023)
- Underwriting Agreement, dated as of February 22, 2023, between Aprea Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on February 24, 2023)
- Form of Registration Rights Agreement, by and among Aprea and certain securityholders (Filed With SEC on May 17, 2022)
- Agreement and Plan of Merger, dated May 16, 2022 by and among Aprea, ATR Merger Sub I Inc., ATR Merger Sub II LLC and Atrin (Filed With SEC on May 17, 2022)
- Description of the Companys Common Stock, $0.001 par value (Filed With SEC on March 16, 2021)
- Companion Diagnostic Agreement dated August 11, 2020, by and between Invivoscribe, Inc. and the Registrant (Filed With SEC on August 11, 2020)
- Description of the Companys Common Stock, $0.001 par value (Filed With SEC on March 27, 2020)
- Employment Agreement between the Registrant and Christian S. Schade (Filed With SEC on September 27, 2019)
- Specimen common stock certificate of the Registrant (Filed With SEC on September 27, 2019)
- Form of 2019 Stock Incentive Plan and form of agreements thereunder (Filed With SEC on September 27, 2019)
- Form of Executive Employment Agreement (Filed With SEC on September 27, 2019)
- Employment Agreement between the Registrant and Lars Abrahmsen, Ph.D (Filed With SEC on September 27, 2019)
- Employment Agreement between the Registrant and Gregory A. Korbel, Ph.D (Filed With SEC on September 27, 2019)
- Employment Agreement between the Registrant and Scott M. Coiante (Filed With SEC on September 27, 2019)
- Master Manufacturing and Supply Agreement, between Aprea Therapeutics AB and Siegfried Hameln GmbH (Filed With SEC on September 25, 2019)
- Form of Amended and Restated Registration Rights Agreement, by and among the Registrant and the shareholders party thereto (Filed With SEC on September 25, 2019)
- Service Agreement, between Aprea AB and Syngene International Private Limited (Filed With SEC on September 25, 2019)
- Form of 2019 Employee Stock Purchase Plan and form of agreements thereunder (Filed With SEC on September 25, 2019)
- Form of 2019 Stock Incentive Plan and form of agreements thereunder (Filed With SEC on September 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 23, 2019)
- APREA THERAPEUTICS, INC. DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on September 23, 2019)
- Service Agreement, between Aprea AB and Syngene International Private Limited (Filed With SEC on September 23, 2019)